Publications

Roumiantsev S, Shah NP, Gorre ME, Nicoll J, Brasher BB, Sawyers CL, Van Etten RA. Clinical resistance to the kinase inhibitor STI-571 in chronic myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain P-loop. Proceedings of the National Academy of Sciences of the United States of America. 2002. PMID: 12149456

Tan SL, Tareen SU, Melville MW, Blakely CM, Katze MG. The direct binding of the catalytic subunit of protein phosphatase 1 to the PKR protein kinase is necessary but not sufficient for inactivation and disruption of enzyme dimer formation. The Journal of biological chemistry. 2002. PMID: 12138106

Ozdemir E, St John LS, Gillespie G, Rowland-Jones S, Champlin RE, Molldrem JJ, Komanduri KV. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. Blood. 2002. PMID: 12393402

Kurizaki T, Okazaki S, Sanderson SD, Colcher D, Enke CA, Tempero MA, Baranowska-Kortylewicz J. Potentiation of radioimmunotherapy with response-selective peptide agonist of human C5a. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2002. PMID: 12097469

Levy JA. HIV-1: hitching a ride on erythrocytes. Lancet (London, England). 2002. PMID: 12103280

Theodosiou A, Ashworth A. MAP kinase phosphatases. Genome biology. 2002. PMID: 12184814

Witt E, Ashworth A. Biomedicine. D-Day for BRCA2. Science (New York, N.Y.). 2002. PMID: 12065747

Harris KA, Harney E, Small EJ. Liposomal doxorubicin for the treatment of hormone-refractory prostate cancer. Clinical prostate cancer. 2002. PMID: 15046711

Small EJ, Roach M. Prostate-specific antigen in prostate cancer: a case study in the development of a tumor marker to monitor recurrence and assess response. Seminars in oncology. 2002. PMID: 12063679

Castelli JC, Deeks SG, Shiboski S, Levy JA. Relationship of CD8(+) T cell noncytotoxic anti-HIV response to CD4(+) T cell number in untreated asymptomatic HIV-infected individuals. Blood. 2002. PMID: 12010831

Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS (London, England). 2002. PMID: 12004270

Linker C, Damon L, Ries C, Navarro W. Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002. PMID: 12011123

Ko AH, Tempero MA. Current and future strategies for combined-modality therapy in pancreatic cancer. Current oncology reports. 2002. PMID: 11937010

Rubenstein J, Fischbein N, Aldape K, Burton E, Shuman M. Hemorrhage and VEGF expression in a case of primary CNS lymphoma. Journal of neuro-oncology. 2002. PMID: 12160141

Moasser MM, Rosen N. The use of molecular markers in farnesyltransferase inhibitor (FTI) therapy of breast cancer. Breast cancer research and treatment. 2002. PMID: 12088116

Bergsland EK, Venook AP. Shedding old paradigms: developing viruses to treat cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002. PMID: 11980991

Rini BI, Small EJ. Prostate cancer update. Current opinion in oncology. 2002. PMID: 11981273

Ross RW, Small EJ. Osteoporosis in men treated with androgen deprivation therapy for prostate cancer. The Journal of urology. 2002. PMID: 11956415

Chiu VK, Bivona T, Hach A, Sajous JB, Silletti J, Wiener H, Johnson RL, Cox AD, Philips MR. Ras signalling on the endoplasmic reticulum and the Golgi. Nature cell biology. 2002. PMID: 11988737

Kohlwes RJ, Chou CL. A curriculum in medical economics for residents. Academic medicine : journal of the Association of American Medical Colleges. 2002. PMID: 12010725